Pure Encapsulations Nitric Oxide Ultra 120C

Item #: PENitOxiULt120
In Stock Usually Ships Within 1 Business Day
Adding to cart… The item has been added

Product Description

Pure Encapsulations Nitric Oxide Ultra (capsules) supports healthy nitric oxide production to promote healthy blood flow and vascular support.
Recommended Use: 2 capsules, 1-2 times daily, between meals, or as directed by a healthcare professional.
  • Promotes healthy blood flow
  • Supports vascular health
  • Made with hypoallergenic, vegan ingredients
Nitric Oxide Ultra (capsules) offers a unique clinically researched blend of cranberry and grape seed extracts combined with citrulline to support blood flow and vascular health, including nitric oxide production, blood flow, and endothelial function.

Healthy blood flow: Nitric Oxide Ultra (capsules) offers a blend of CranLoad and citrulline to support healthy blood flow by targeting nitric oxide production and flow-mediated dilation.

Athletic Recovery: In a double-blind, placebo-controlled, pilot study, the effects of pre-exercise CranLoad administration was investigated in high-profile athletes. The athletes performed a 3 km stationary cycling time trial after consuming either CranLoad or a placebo. Results of the pilot study show a significant decrease in blood lactate in those athletes consuming CranLoad compared to placebo (Figure 2). This study supports the concept that CranLoad enhances blood flow and is associated with enhanced lactate clearance during high-intensity exercise. This outcome suggests enhanced recovery.

Label Information

Gluten Free

Gluten Free

Pure Encapsulations Nitric Oxide Ultra (capsules) Facts:

2 vegetarian capsules contain:

  • l-citrulline (free-form) 1,000 mg
  • CranLoad proprietary blend 382 mg
  • providing cranberry (Vaccinium macrocarpon) extract (fruit) and grape (Vitis vinifera) extract (seed)
Other Ingredients: vegetarian capsule (cellulose, water), ascorbyl palmitate.

CranLoad is a registered trademark used by Pure Encapsulations under license.